Kappos, L. Et Al. 2008. Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study. LANCET , vol.372, no.9648 , 1463-1472.

Kappos, L., Gold, R., Miller, D. H., MacManus, D. G., Havrdova, E., Limmroth, V., ... Polman, C. H.(2008). Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study. LANCET , vol.372, no.9648, 1463-1472.

Kappos, Ludwig Et Al. "Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study," LANCET , vol.372, no.9648, 1463-1472, 2008

Kappos, Ludwig Et Al. "Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study." LANCET , vol.372, no.9648, pp.1463-1472, 2008

Kappos, L. Et Al. (2008) . "Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study." LANCET , vol.372, no.9648, pp.1463-1472.

@article{article, author={Ludwig Kappos Et Al. }, title={Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study}, journal={LANCET}, year=2008, pages={1463-1472} }